Escalate: Increase by 2.5 mg every 4 weeks as tolerated
Wegovy is an under-the-skin, self-administered injectable prescription medicine for patients with either: A body mass index (BMI) of 30 kg/m2 or greater A BMI of 27 kg/m2 or greater with at least one weight-related ailment such as type 2 diabetes, hypertension, sleep apnea, or others
It not only aids in managing blood sugar levels but also supports weight loss by reducing appetite and food intake
If youve been struggling to lose weight on your own, feel stuck in your current routine, or have gained weight due to hormonal changes, stress, or lifestyle changes, you may be a candidate for our weight loss in Port Orange

Patients who may particularly benefit from the oral option include: Those with needle concerns: While modern GLP-1 injections use very small needles, some patients have significant needle phobia that prevents them from starting treatment Patients seeking a less medical approach: Some individuals prefer the familiarity of taking a daily pill over self-injecting Weight maintenance candidates: Emerging research suggests oral GLP-1s may be effective for maintaining weight loss after achieving goals on injectable medications Those with access challenges: Pills dont require refrigeration and may be easier to travel with Important Considerations Before Switching or Starting The Wegovy pill will be available in January 2026, with the starting 1.5mg dose priced at $149 per month for cash-paying patients
By starting with an online intake form, you can quickly find out if weight loss medication covered by insurance is right for you